Tseng GY - Search Results

1

A prospective, randomized trial of large- versus small-volume endoscopic injection of epinephrine for peptic ulcer bleeding.

Lin HJ, Hsieh YH, Tseng GY, Perng CL, Chang FY, Lee SD. Lin HJ, et al. Among authors: tseng gy. Gastrointest Endosc. 2002 May;55(6):615-9. doi: 10.1067/mge.2002.123271. Gastrointest Endosc. 2002. PMID: 11979239 Clinical Trial.

2

Endoscopic injection with fibrin sealant versus epinephrine for arrest of peptic ulcer bleeding: a randomized, comparative trial.

Lin HJ, Hsieh YH, Tseng GY, Perng CL, Chang FY, Lee SD. Lin HJ, et al. Among authors: tseng gy. J Clin Gastroenterol. 2002 Sep;35(3):218-21. doi: 10.1097/00004836-200209000-00004. J Clin Gastroenterol. 2002. PMID: 12192196 Clinical Trial.

3

A prospective, randomized trial of endoscopic hemoclip versus heater probe thermocoagulation for peptic ulcer bleeding.

Lin HJ, Hsieh YH, Tseng GY, Perng CL, Chang FY, Lee SD. Lin HJ, et al. Among authors: tseng gy. Am J Gastroenterol. 2002 Sep;97(9):2250-4. doi: 10.1111/j.1572-0241.2002.05978.x. Am J Gastroenterol. 2002. PMID: 12358241 Clinical Trial.

4

Genotypes of Helicobacter pylori in patients with peptic ulcer bleeding.

Perng CL, Lin HJ, Lo WC, Tseng GY, Sun IC, Ou YH. Perng CL, et al. Among authors: tseng gy. World J Gastroenterol. 2004 Feb 15;10(4):602-5. doi: 10.3748/wjg.v10.i4.602. World J Gastroenterol. 2004. PMID: 14966926 Free PMC article.

5

Poor responders to intravenous omeprazole in patients with peptic ulcer bleeding.

Hsieh YH, Lin HJ, Tseng GY, Perng CL, Wang K, Lo WC, Chang FY, Lee SD. Hsieh YH, et al. Among authors: tseng gy. Hepatogastroenterology. 2004 Jan-Feb;51(55):316-9. Hepatogastroenterology. 2004. PMID: 15011893

6

Helicobacter pylori stool antigen test in patients with bleeding peptic ulcers.

Lin HJ, Lo WC, Perng CL, Li AF, Tseng GY, Sun IC, Ou YH. Lin HJ, et al. Among authors: tseng gy. Helicobacter. 2004 Dec;9(6):663-8. doi: 10.1111/j.1083-4389.2004.00276.x. Helicobacter. 2004. PMID: 15610081 Clinical Trial.

7

Peptic ulcer bleeding outcomes adversely affected by end-stage renal disease.

Tseng GY, Lin HJ. Tseng GY, et al. Gastrointest Endosc. 2010 Jun;71(7):1333-4; author reply 1334. doi: 10.1016/j.gie.2009.09.028. Gastrointest Endosc. 2010. PMID: 20598264 No abstract available.

8

Helicobacter pylori cagA, iceA and vacA status in Taiwanese patients with peptic ulcer and gastritis.

Perng CL, Lin HJ, Sun IC, Tseng GY, Facg. Perng CL, et al. Among authors: tseng gy. J Gastroenterol Hepatol. 2003 Nov;18(11):1244-9. doi: 10.1046/j.1440-1746.2003.03214.x. J Gastroenterol Hepatol. 2003. PMID: 14535980

9

Helicobacter pylori cagA, iceA and vacA genotypes in patients with gastric cancer in Taiwan.

Lin HJ, Perng CL, Lo WC, Wu CW, Tseng GY, Li AF, Sun IC, Ou YH. Lin HJ, et al. Among authors: tseng gy. World J Gastroenterol. 2004 Sep 1;10(17):2493-7. doi: 10.3748/wjg.v10.i17.2493. World J Gastroenterol. 2004. PMID: 15300891 Free PMC article.

10

The effect of H2-receptor antagonist and proton pump inhibitor on microbial proliferation in the stomach.

Wang K, Lin HJ, Perng CL, Tseng GY, Yu KW, Chang FY, Lee SD. Wang K, et al. Among authors: tseng gy. Hepatogastroenterology. 2004 Sep-Oct;51(59):1540-3. Hepatogastroenterology. 2004. PMID: 15362796 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

38 results

Search Page

Filters